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Abstract: 
Diabetes, Obesity and Neurological disturbances, most often show co-occurrence. There has been an extensive research in this 
domain, but the exact mechanism underlying the co-occurrence of the three conditions is still an enigma. The current paper is an 
approach to establish the role of Butyryl cholinesterase (BCHE) in Diabetes, Obesity and Neurological disorders by performing a 
comparative analysis with Neuroligin (NLGN2) a protein belonging to the same family. BCHE has its role in glucose regulation, 
Lipid metabolism and nerve signaling. Emphasis is laid on BCHE’s diverse functions whose impediment affects the above 
mentioned metabolic pathways. Insilco techniques were employed to analyze the sequence, structural and functional similarities of 
the two proteins. A point mutation is focused which is common to both BCHE and Neuroligin. The mutation occurs at the 
homologous position in both the proteins making them deficient. This affects the three metabolic pathways leading to the 
respective disorders. The work describes the pathway that describes the role of BCHE in the onset of obesity mediated diabetes. 
The pathway further explains the association between Diabetes, Obesity and neurological disturbances. 
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Background: 
Diabetes is one of the most common disorders for the people 
of all age groups. Vast research is carried out in solving this 
major problem. There are several proteins that are involved in 
the onset of diabetes. BCHE (Butyryl cholinesterase) is one 
such protein having an important role in diabetes whose exact 
mechanism is yet to be revealed.  BCHE has an important role 
in the regulation of insulin concentration and lipid levels [1]. It 
has wide diversity of functions. Being a member of esterase’s 
it has an important role in nerve regulation and signal 
transduction [2]. BCHE is reported to have its involvement in 
adiposity and insulin resistance [3], thereby regulating lipid 
and glucose concentrations respectively. This diverse group of 
functions makes the protein an important factor in the onset of 
Diabetes and associates it with Obesity and Nerve 
disturbances. It has a length of 602 amino acids with three 
domains which are overlapping [4], an abhydrolase, CO 
esterase and an ACHE which imparts diverse functions to the 
protein.  
 
Neuroligin (NLGN) is a cell surface membrane protein, 
involved in synapse formation at the nerve junctions [5]. It 
mediates signaling across the synapse and affects the 
properties of neural networks by specifying synaptic 
functions. Members of this family may act as splice site-
specific ligands for beta-Neurexins and may be involved in the 
formation and remodeling of central nervous system synapses 
[6]. It resides on the P arm of the 17th chromosome in man 
with a length of 835 amino acids. The domains are similar to 
BCHE, an Abhydrolase and a CO Esterase that are 
overlapping.  
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Neuroligin, Acetyl choline esterase (ACHE) and Butyryl 
choline esterase (BCHE) belong to a common family of 
proteins called alpha beta hydrolases [7] .Proteins of the 
alpha/beta-hydrolase fold family share a common structural 
fold, but perform a diverse set of functions. Neuroligins are a 
class of proteins that include Neuroligin 1, 2, 3 and 4 with 
further sub groups. They are cell surface proteins that are 
involved in the cell to cell adhesion [8]. Members of the Alpha 
b e t a  h y d r o l a s e  f o l d  f a m i l y  a r e  r e p o r t e d  t o  h a v e  a  c o m m o n  
point mutation R to C which causes the respective proteins to 
get retained within the Endoplasmic reticulum, thereby 
leading to various multi factorial disorders [9]. 
 
Methodology: 
Identification of proteins sharing sequence similarity to 
BCHE 
Proteins sharing sequence similarity to BCHE were identified 
using TFASTY. It compares the protein sequences to the 
translated DNA sequences with frame shifts [10].TFASTY uses 
the same heuristic algorithm as FASTA. 
 
Evaluation of the proteins for sequence similarity  
All the sequences that were found to be similar were further 
validated using BLAST P (pair wise sequence similarity) that 
can provide the percentage of similarity between the two 
sequences.  
 
Identification of the homologous sites on the two proteins 
The site that is reported to have a mutation at the homologous 
positions in the two proteins was identified using EMBOSS 
NEEDLE  [11]. Pair wise Sequence Alignment is used to 
identify regions of similarity that may indicate functional, 
structural and/or evolutionary relationships between two 
biological sequences. 
 
Analysis of Domains within the proteins 
The functional sites that are present on both the proteins have 
been identified using SMART. The position, classification and 
function of the total number of domains present in the 
submitted sequence can be analyzed using SMART [12]. 
 
Classification study and functional assessment of the protein  
To indicate the effect of BCHE in lipid metabolism using its 
family classification CDD (Conserved Domain Data base) has 
been used. It gives complete information of various domains 
and their relation to the families of proteins. 
 
Active and binding site prediction within the proteins 
Binding sites that are present in the protein were analyzed 
using several Insilco tools like CASTP, QSITE FINDER and 
POCKET FINDER. These tools will locate the preferable sites 
that are energetically and stearically suitable for ligand 
binding. These are the most accessible areas on the receptors. 
 
Comparative structural analysis of the two proteins 
Secondary and tertiary structural analysis is done to compare 
the location of the mutational site on the two proteins. 
SOPMA is a proteomic tool of EXPASY [13] which gives the 
information regarding the secondary structural conformations 
of the given protein. CPH, HHPRED and PHYRE are 
employed to analyze the tertiary structures of the protein 
 
Visualization of the 3D structures of the two proteins 
To visualize the structure of the protein against X, Y and Z 
axis RASMOL is employed. The software is basically a 
command line programme that is executed by commands. The 
site important in mutation is identified and visualized. 
 
Analyzing the stability of the mutated protein  
To check the effect of the mutation on the energy and stability 
of the protein structure I MUTANT [14] is employed. It gives 
the stability index of the point mutations based on the neural 
network programme. 
 
Designing a pathway to associate the onset of the three 
disorders 
By aggregating the results from all the above analysis and 
reports a pathway has been proposed that can considerably 
justify the association and co occurrence of Diabetes, Obesity 
and Neurological disturbances with respect to BCHE. The 
pathway also details the mechanism by which BCHE is 
involved in causing the three disorders. 
 
 
Figure 1: EMBOSS NEEDLE between BCHE and Neuroligin 
 
Discussion: 
Table1 (see supplementary material) shows that there are 5 
proteins belonging to different classes of neuroligins which 
share sequence similarity to BCHE. All the proteins showed 
more than 30% similarity in TFASTY which was further 
validated using BLAST P. 
 
(Figure 1) shows the alignment of BCHE and Neuroligin. The 
homologous site that is prone for mutation is highlighted. The 
sites are 414 and 448 of BCHE and Neuroligin 2 respectively. 
SMART analysis provided the domain information regarding 
the two proteins. BCHE has three overlapping domains 
Abhydrolase (138 – 269), a CO Esterase (9 – 550) and an ACHE 
(565 – 602). The domains of neuroligin are Abhydrolase (180 - 
333) and a CO Esterase (30 – 601). These results indicate that 
both the proteins share two domains in common a CO 
Esterase and an Abhydrolase, which represents their 
functional similarity. (Figure 3) depicts that neuroligin has 
fingerprints that are specific to two classes Cholinesterase and 
Neuroligin, Which is an indication of its functional similarity 
to BCHE.  
 
 
Figure 2: Finger print identification of Neuroligin 
 
This was followed by CDD analysis which showed the 
presence of a functional region “aes” from 125 to 229 of BCHE, 
which has a major role in Lipid metabolism. These results 
indicate that BCHE has a role in Lipid metabolism.   Structural BIOINFORMATION  open access 
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analysis using EXPASY server showed that the site under 
study is located in the extended strand conformation of both 
BCHE and Neuroligin. For the determination of the 3D 
structures of proteins, tools like CPH, HHPRED and Phyre 
have been employed. The PDB id’s 2WIK and 3BE8 are 
selected as the best one for BCHE and Neuroligin respectively 
based on the results. I mutant was used to study the stability 
of the mutated protein. 
 
Position       WT      NEW        Stability   RI     RSA 
   386             R            C           Decrease     2      11.8 
WT: Native amino acid; NEW: New amino acid; RI: Reliability 
index; RSA: Relative solvent accessible area. 
 
The stability check shows that the mutation causes a decrease 
in the stability of the protein when compared to the native 
protein. The 414 site of the sequence would be 386 in structure. 
Binding and active sites that are present within BCHE were 
analyzed using tools like CAST P, Pocket finder and Q site 
finder. The results showed that the mutation under study was 
falling under one of the pockets which indicate that it causes a 
major effect on the functional properties of the protein. This 
emphasizes the importance of the mutation.  
 
 
Figure 3:  Pathway that associates Diabetes, Obesity and 
Neurological disturbances. 
 
The pathway explains the mechanism of co occurrence of 
Diabetes, obesity and Neurological disturbances. It describes 
the role of BCHE in all the three disorders (Figure 3). The 
work emphasizes the role of BCHE in causing Diabetes, 
Obesity and Neurological disturbances with focus on its multi 
functional ability. The importance of BCHE in Nerve 
regulation is shown by considering its Sequence, structural 
and functional similarity to Neuroligin. BCHE, ACHE and 
Neuroligin structurally belong to a family of alpha beta 
hydrolase fold as reported, which can also be inferred from 
the similar structural patterns shown by FINGERPRINT 
SCAN. The presence of common domains by SMART and 
CDD analysis depicts the probable role of these proteins in 
insulin signaling. 
 
A point mutation R to C is known which is specific to alpha 
beta hydrolase fold family of proteins. Reports show that the 
mutation occurs in the homologous sites in all the three 
proteins which was further proved by EMBOSS. This mutation 
leads to the retention of the respective proteins in 
Endoplasmic Reticulum thereby causing their deficiency.   
Neuroligin and BCHE both are involved in regulation of 
insulin production by different mechanisms [15]. Neuroligin-2 
is expressed on the β cell surface and binds with high affinity 
to another β-cell surface protein. Extracellular interactions 
involving NL-2 increase insulin expression and secretion by β 
cells. These results are consistent with the hypothesis that NL-
2 promotes the development and maintenance of the insulin 
secretory machinery in β cells through trans-cellular 
interactions [15].  
 
BCHE is a member of Esterase Lipase super family. Through 
CDD analysis, it was found that BCHE contains a region Aes 
which is involved in lipid metabolism thus justifying the role 
of this protein in regulation of lipids. The role of BCHE in 
glucose metabolism could be through insulin signaling. Any 
alteration to this protein leads to a disturbance in its function. 
The point mutation R414C is known that causes the retention 
of the protein within the Endoplasmic reticulum in turn leads 
to deficiency. This condition causes a disturbance in the 
insulin signaling thus hinders the glucose metabolism. This 
leads to the onset of diabetes. BCHE being a member of Ester 
lipase super family has a role in Nerve signal transduction. 
The deficiency of BCHE alters the signal transduction of 
neurons, a potential cause of Neurological disturbances. 
 
Further the mutation causes alteration in the lipid metabolism 
leading to the accumulation of fats and provoking the onset of 
Obesity.  This suggests the probable role of BCHE in Obesity 
mediated Diabetes. Reports show that there are two 
transcription factors FOXA 2 and HNF1A that become non-
functional due to the accumulation of fat in obese condition 
[16]. These factors are required for the activity of GnT-4a 
glycosyl transferase which regulates the glucose metabolism 
by affecting glucose transporters [16] Altered transcription 
factors cause inactivation of GnT-4a glycosyl transferase 
leading to the disturbance in glucose metabolism causing 
Diabetes. 
 
The pathway proposes two possible mechanisms by which 
BCHE is involved in Diabetes, Direct role through insulin 
signaling abnormality and an indirect role through Obesity 
mediated Diabetes. The pathway demonstrates the association 
of BCHE to Diabetes, Obesity and Neurological disturbances. 
This mechanism can further support the hypothesis that 
Obesity, Diabetes and Neurological abnormalities are 
associated to each other in their onset. 
 
Conclusion: 
The role of BCHE in Diabetes, Obesity and Neurological 
Disorders has been analyzed through the above Insilico 
approach. Association of BCHE in the onset of the three BIOINFORMATION  open access 
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disorders and the co occurrence of the three conditions has 
been proposed by means of a pathway. 
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Supplementary material:  
 
Table 1: Proteins that are found to have sequence similarity to BCHE as shown by TFASTY and validated using BLASTP 
S. no  Name  Accession No  % Identity using TFASTY  % Identity using BLAST 
1  Neuroligin 4, X-L  31317255  34.526%  34% 
2  Neurlogin 4, Y  256222770  34.165%  34% 
3 Neuroligin  3  262359973  34.549%  34% 
4 Neuroligin  2  31317254  33.509%  34% 
5 Neuroligin  1  31317253  33.836%  33% 
 